This is especially apparent in the tumor microenvironment where DCs can be educated toward a protumoral tolerogenic phenotype, characterized by low costimulatory molecule expression, poor antigen presentation, and high expression of Arg1 and IDO [170,171]. The gene discussed is ARG1; the disease is neoplasm.